NCT00022113View on ClinicalTrials.gov

EMD 121974 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

May 31, 2005

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

cilengitide

Given IV

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

80217-3364

University of Colorado, Denver

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00022113 - EMD 121974 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter